Unknown

Dataset Information

0

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes.


ABSTRACT:

SUBMITTER: Hu JY 

PROVIDER: S-EPMC8478367 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2922594 | biostudies-literature
| S-EPMC5295378 | biostudies-literature
| S-EPMC3630260 | biostudies-literature
| S-EPMC3365112 | biostudies-literature
| S-EPMC7258879 | biostudies-literature
| S-EPMC5735335 | biostudies-literature
| S-EPMC4063096 | biostudies-other
| S-EPMC6918008 | biostudies-literature
| S-EPMC3588862 | biostudies-other
| S-EPMC6339876 | biostudies-literature